BCM
VRTX icon

Brookstone Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Brookstone Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
500
+3
+0.6% +$1.33K ﹤0.01% 1170
2026
Q1 		$222K Sell
497
-38
-7% -$17.7K ﹤0.01% 1132
2025
Q4 		$243K Sell
535
-4
-0.7% -$1.72K ﹤0.01% 1054
2025
Q3 		$211K Buy
+539
New +$225K ﹤0.01% 1082
2025
Q2 		– Sell
-2,264
Closed -$1.1M – 1100
2025
Q1 		$1.1M Sell
2,264
-56
-2% -$26.1K 0.02% 532
2024
Q4 		$934K Sell
2,320
-2
-0.1% -$927 0.01% 550
2024
Q3 		$1.08M Sell
2,322
-169
-7% -$81.2K 0.02% 508
2024
Q2 		$1.22M Buy
2,491
+123
+5% +$53.4K 0.02% 464
2024
Q1 		$990K Buy
2,368
+237
+11% +$100K 0.02% 493
2023
Q4 		$867K Sell
2,131
-1,206
-36% -$446K 0.02% 488
2023
Q3 		$1.22M Buy
3,337
+1,208
+57% +$422K 0.03% 393
2023
Q2 		$720K Sell
2,129
-34
-2% -$11.5K 0.01% 496
2023
Q1 		$709K Sell
2,163
-232
-10% -$69.6K 0.01% 522
2022
Q4 		$695K Buy
2,395
+1,681
+235% +$512K 0.01% 515
2022
Q3 		$207K Buy
+714
New +$205K ﹤0.01% 743
2021
Q3 		– Sell
-1,151
Closed -$228K – 794
2021
Q2 		$228K Buy
+1,151
New +$241K ﹤0.01% 652
2020
Q3 		– Sell
-4,055
Closed -$1.18M – 472
2020
Q2 		$1.18M Buy
+4,055
New +$1.1M 0.07% 158
2015
Q4 		– Sell
-13
Closed -$1K – 866
2015
Q3 		$1K Hold
13
– – ﹤0.01% 1857
2015
Q2 		$2K Buy
+13
New +$1.64K ﹤0.01% 1837

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Brookstone Capital Management's VRTX Position: Q2 2026 in Review

Brookstone Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.6% in Q2 2026, buying an estimated $1.33K and bringing the position to 500 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1170.

Brookstone Capital Management first reported a position in VRTX in Q2 2015 and has held it in 19 quarters since. The position peaked at $1.22M in Q3 2023. 258 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Brookstone Capital Management held 500 shares of Vertex Pharmaceuticals worth $248K as of Q2 2026.
  • Brookstone Capital Management bought 3 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
  • Vertex Pharmaceuticals made up ﹤0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #1170 holding.
  • Brookstone Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 19 quarters since.
  • Brookstone Capital Management's Vertex Pharmaceuticals position peaked at $1.22M in Q3 2023.
  • 258 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.